Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
Date:11/11/2008

358,629 341,214

Payroll taxes payable 17,354 39,939

Dividend payable -- 378,545

Other current liabilities 113,866 142,733

Total current liabilities: 3,429,685 3,910,548

Total liabilities: 3,429,685 3,910,548

Stockholders' equity:

Common stock, $0.001 par value,

50,000,000 shares authorized,

15,465,563 and 14,738,450

shares issued and outstanding at

September 30, 2008 and June 30, 2008 15,466 14,739

Common stock dividend distributable 226 --

Series A convertible preferred

stock, $0.001 par value,8,893,750

9,384,375 shares issued and

outstanding at September 30, 2008

and June 30, 2008 8,894 9,384

Additional paid-in capital 18,741,688 18,002,439

Statutory reserve 1,584,154 1,380,806

Retained earnings 12,189,443 10,963,131

Accumulated other comprehensive income 2,567,308 2,477,874

Total stockholders' equity: 35,107,179 32,848,373

Total liabilities and

stockholders' equity: $38,536,864 $36,758,921

Consolidated Statements of Operations and Comprehensive Income

(Unaudited)

For the Three Months Ended

September 30,

2008 2007

Sales: $9,561,940 $7,169,493

Cost of goods
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
2. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
3. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
4. Tianyin Pharmaceutical Appoints Three New Independent Board Members
5. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
6. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
7. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
8. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
9. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
10. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
11. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... January 15, 2014 2013 was a ... Brain State Technologies®. They saw continued independent research led ... who were awarded a $1 million grant from the ... “Brain and Behavior” a peer reviewed journal, Amy Grant ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... HOUSTON, April 23, 2012  Melanie Pita, J.D., will ... records journey for rural hospitals as she presents ... Rural Health Association,s Annual Conference, being held  April ... in Effingham, Ill.   During the ...
... Ahram Biosystems, Inc., a leading innovator of new life ... the economy model of its innovative portable PCR system. The ... PCR amplification with high speed and sensitivity in a fully ... provides three " Standard Fast" speed levels delivering 30-cycle ...
... American Telemedicine Association is pleased to host the ATA ... San Jose, California ( www.ata2012.com ).  ATA 2012 is ... aspects of telemedicine, telehealth, mHealth and remote healthcare technology. ... you,re a seasoned professional, ATA 2012 provides the information ...
Cached Biology Technology:Prognosis HIS Executive Slated To Offer EHR Advice At Illinois Rural Health Association Conference 2Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series 2Free Expo-Hall Passes for ATA 2012 2
(Date:7/9/2014)... With grilling season upon us, many backyard cooks are ... fatty hot dogs. But low fat can sometimes mean ... addressing the texture problem in low-fat wieners that are ... study was published in ACS, Journal of Agricultural ... colleagues note that hot-dog consumers have come to expect ...
(Date:7/9/2014)... challenges the commonly held belief that birds evolved from ... The birdlike fossil is actually not a dinosaur, as ... tiny tree-climbing animal that could glide, say American researchers ... and Alan Feduccia of the University of North Carolina. ... . , The fossil of the Scansoriopteryx ...
(Date:7/9/2014)... at the NIH,s National Center for Advancing ... treat sickle cell disease has been acquired ... candidate, Aes-103, is the first specifically developed ... sickle cell disease. Baxter now will advance ... approval and commercialization. , Sickle cell disease ...
Breaking Biology News(10 mins):Researchers declassify dinosaurs as being the great-great-grandparents of birds 2First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
... used since the 1930s to estimate the abundance of ... patrols are effective at reducing poaching of elephants, African ... in Tanzania. , "Wildlife within protected areas is ... trades, and many argue that enforcement within protected areas ...
... Institut Pasteur has recently shown that the tuberculosis bacillus ... cells. This formidable pathogen is protected against even the ... may remain dormant for years. This discovery, published in ... fighting tuberculosis. Attempts to eradicate the bacillus entirely from ...
... cancer therapy has been identified by Monash University scientists ... gene involved in cancer development. , A team led ... Immunology, has identified two proteins that are involved in ... that is essential if cancer cells are to proliferate. ...
Cached Biology News:Serengeti patrols cut poaching of buffalo, elephants, rhinos 2Tuberculosis: The bacillus takes refuge in adipose cells 2New target for cancer therapy identified 2
WD-repeat protein 4...
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
... human omental preadipocytes are ... otherwise healthy donors. There ... diabetic cells. Please inquire ... media also available. Academic ...
ASCIZ...
Biology Products: